KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Capital Employed (2016 - 2025)

Sarepta Therapeutics (SRPT) has 15 years of Return on Capital Employed data on record, last reported at 0.13% in Q2 2025.

  • For Q2 2025, Return on Capital Employed rose 11.0% year-over-year to 0.13%; the TTM value through Jun 2025 reached 0.13%, up 11.0%, while the annual FY2024 figure was 0.08%, 18.0% up from the prior year.
  • Return on Capital Employed reached 0.13% in Q2 2025 per SRPT's latest filing, up from 0.07% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.13% in Q2 2025 and bottomed at 0.27% in Q2 2021.
  • Average Return on Capital Employed over 5 years is 0.13%, with a median of 0.18% recorded in 2022.
  • Peak YoY movement for Return on Capital Employed: fell -8bps in 2023, then grew 21bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 0.19% in 2021, then fell by -13bps to 0.21% in 2022, then skyrocketed by 50bps to 0.11% in 2023, then surged by 168bps to 0.07% in 2024, then surged by 78bps to 0.13% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.13% in Q2 2025, 0.07% in Q4 2024, and 0.03% in Q3 2024.